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Research in the life sciences requires ready access to primary data, derived
information and relevant knowledge from a multitude of sources.
Integration and interoperability of such resources are crucial for sharing
content across research domains relevant to the life sciences. In this article
we present a perspective review of data integration with emphasis on a
semantics driven approach to data integration that pushes content into a
shared infrastructure, reduces data redundancy and clarifies any
inconsistencies. This enables much improved access to life science data
from numerous primary sources. The Semantic Enrichment of the
Scientific Literature (SESL) pilot project demonstrates feasibility for using
already available open semantic web standards and technologies to
integrate public and proprietary data resources, which span structured and
unstructured content. This has been accomplished through a
precompetitive consortium, which provides a cost effective approach for
numerous stakeholders to work together to solve common problems.
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most researchers to find and access data to drive new insights and
discoveries. It is essential that these researchers are able to query a
wide variety of data sources through well-designed interfaces to
gain ready access to all relevant data in the scientific literature,
public and proprietary databases. In this article we review current
approaches to data integration with particular emphasis on
semantic web standards and technologies. These have been used
to demonstrate technical feasibility for Virtual Knowledge Broker
(VKB) services through the public Semantic Enrichment of the
Scientific Literature (SESL) demonstrator (http://www.pistoia-
sesl.org) which is focussed on human genes and uses the disease,
Type 2 diabetes mellitus (T2DM), as the exemplar to test the
premise [1]. This approach to data integration promises to help
researchers cope better with the data deluge and to create new
business opportunities for the data providers.
The data deluge challenge
Modern life science research generates large volumes of experi-
mental data by use of an ever-increasing number of technologies,
especially those that operate in high throughput, such as biolo-
gical screening, microarrays and next generation sequencing.
These sources of structured data and accompanying metadata
are also paralleled by enormous growth of unstructured data such
as text found in the scientific literature. The researcher faces an
enormous challenge in fully exploiting all these valuable resources
to derive new insights and drive scientific discovery.
Hypotheses, conceptualised data and generalised facts from life
science research are mainly delivered through the scientific litera-
ture comprising primary research articles, scientific reviews, con-
ference proceedings, clinical data records and patents. The
evidence has been gathered from fundamental research such as
transgenic experiments (e.g. gene knockouts), RNA and protein
expression analyses, population genetics (e.g. GWAS), clinical
studies and crop studies [2]. Increasingly, scientific assertions
are produced from the life science literature through automated
text processing methods in combination with subsequent curation
work [3,4].
Structured data from scientific databases and unstructured data
from the scientific literature form the two pillars of scientific work.
Primary research generates experimental evidence that is stored in
numerous data repositories; for example, gene expression data
resides in GEO/ArrayExpress [5] and information on the genetic
causes of diseases can be found in the OMIM (Online Mendelian
Inheritance in Man) database [6]. Such data are not always readily
accessible within these resources, often individual data resources
are incomplete and the delivered facts can be disconnected.
A shared data marketplace for life sciences
Retrieving only the pertinent data in the post-genomic era is very
much like looking for needles in haystacks. Firstly the relevant
data sources (haystacks) have to be found and then each has to be
searched, often separately, to locate the relevant data (needles).
Surely, it would be far better if the user experience for the life
science researcher was much more like that devised so successfully
by internet businesses, such as online retail and travel or insurance
comparison sites, which broker ready access to relevant informa-
tion through a unified user interface.The role of a knowledge broker has been described in the field of
health care practitioner behaviour, which promotes interaction
between researchers, patients and decision makers [7]. In this
context, knowledge brokering enables mutual understanding of
goals and culture, which also informs clinical policy and practise
[8,9]. The knowledge broker role can also be found in the life
sciences domain where an individual may provide a variety of
expert analytical services, such as bioinformatics and text mining,
and present the outcomes in a single aggregate report. Extending
this approach to the user experience for unified search and retrie-
val, accessing numerous sources of data, describes the notion of a
VKB [10].
In this review we argue that VKB services applied to life science
data could ensure ready access to, and integration across, numer-
ous primary data resources. It would also enable data providers to
push their content to a virtual marketplace. Implementation of
existing open standards should allow all data and information
providers to shape their own content distribution, which could be
delivered to a marketplace via a web portal in response to a
researcher’s queries. A scientist looking, for example, for informa-
tion on genes causing disease in both the published literature and
biological databases would not have to search each source sepa-
rately, or compare and validate the retrieved results against each
other, but would receive the aggregated information from the
different available sources through a single interface designed
for this purpose.
Data integration and Virtual Knowledge Broker
services
Efforts to automatically process the scientific literature, such as
PubMed abstracts and open access literature, have not yet led to
significant repositories of facts, nor to the establishment of rele-
vant and generally adopted data standards for the exchange of
content between publishers and authors. To date, although the
entire scientific research and publisher community can see real
value in this approach, the integration of facts with data reposi-
tories and data distribution has not yet been achieved [11].
Louie et al. [12] described the challenges and opportunities of
data integration for genomic medicine, and these remain the same
today. Data marts (or warehouses) and the federation of data are
the traditional approaches used to build large-scale infrastructures
as illustrated in Fig. 1. In the case of the mart, all data are integrated
into a single infrastructure. This contrasts with federation, such as
with caGrid, where scalable integration and interoperability is
achieved through the harmonisation of separate database schemas
[13]. These solutions are limited as it is very difficult to relocate or
include additional types of data without significant development
efforts. However, it is possible to design a more flexible infrastruc-
ture by utilising brokering services, leading to a solution that
would even be open to shape workflows from external clients,
such as the SADI services [14].
Open standards on the web, such as the Resource Description
Framework (RDF) and the Web Ontology Language (OWL), enable
data integration of distributed resources with encoded meaning
(i.e. semantics). Semantic web standards and technologies are well
suited to meet the challenges of data integration, as evidenced by a
growing number of bioinformatics resources where data are dis-
tributed in an open infrastructure, such as the Linked Life Datawww.drugdiscoverytoday.com 429
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FIGURE 1
Different data integration solutions. Comparing data integration of different kinds: mart (left), federation (middle) and brokering (right). In the mart, all data are
integrated into a complex schema, whereas federation requires that data consistency is achieved through interoperable data export and import interfaces.
Brokering requires a Virtual Knowledge Broker (VKB), which uses open standards to expose the data and compliance with provenance and licensing (P&L) to be
able to integrate the content from the primary data sources into the user-oriented data repository.
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rocommons [16] and the SESL public demonstrator, which is
summarised in the next section.
The integration of structured and unstructured data into an
open infrastructure requires shared data standards. Several open
standards for better semantic support have been proposed, such as
the use of open access terminologies and ontologies [11], as well as
the application of data exchange formats such as RDF and OWL
[17]. These enable communication across the web and support
both sharing and exploitation of data resources. The Link Open
Drug Data (LODD) task force within the World Wide Web Con-
sortium (W3C) is a good example of an emerging technology for
linking data sets to enable data integration that support research in
academia and industry [18].
Thinking beyond data integration, semantic interoperability
and distributed exploitation of public data, numerous require-
ments have to be met to support the life science research com-
munity. First, public and proprietary data have to be fully
accessible in a shared and seamless manner, including the full
text of the scientific literature. Second, different kinds of numer-
ical data with semantic annotations, such as experimental
metadata, must be included and even, ideally, extended to
supplementary data, tables and figures from the scientific pub-
lications. Third, the semantic facts have to be integrated into and
embedded in the shared infrastructure. The SESL demonstrator,
summarised in the next section, shows that it is feasible to satisfy
these requirements and to achieve semantic integration of430 www.drugdiscoverytoday.comliterature and data resources through the implementation of
VKB services.
Towards Virtual Knowledge Broker services
Unstructured data sources: full text scientific literature
The participating data provider companies (Elsevier, Nature Pub-
lishing Group, Oxford University Press, Royal Society of Chem-
istry) contributed 638,088 scientific full text publications to the
SESL project and a further 232,665 full text documents were
sourced from Europe PubMed Central. These two sources formed
the literature corpus used to develop the brokering framework. The
publicly accessible SESL demonstrator contains a subset of the
literature corpus used for its development, comprising 20,168 full
text publications, which were released to the public domain by the
data providers for this purpose.
All full text documents in the literature corpus were processed in
a similar manner. The identification of gene and protein names
was achieved using the terminological resource, LexEBI, which
served as a term repository for the biomedical domain and pro-
vides references to the entries from the different primary data
providers [19]. Identification of diseases was achieved using UMLS
terminological resource [20]. All sentences containing a pair com-
posed of a gene and a disease were identified and loaded into a
triple store database. Sentence provenance was retained as part of
the process, that is, the reference to the sentence, paragraph and
the document source, the digital object identifier (DOI) and asso-
ciated publication reference data.
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The current UniProtKB triple store delivers an integrated repre-
sentation of the database based on RDF triples [21]. The human
subset of this data source used to build the SESL demonstrator
contains 20,272 proteins, 100,723 functional annotations and
13,897 protein–protein interactions, all rendered as triples. Data
relevant to T2DM was imported from Gene eXpression Atlas (GXA)
resulting in the integration of data from 138 experiments [5].
Disease annotations from the Experimental Factor Ontology
(EFO) used in the GXA data repository were normalised to the
Disease Ontology (DO) so the existing mappings to UMLS could be
used. Gene expression data were also loaded for the pancreas
because this organ has a major role in blood sugar regulation,
which is fundamental to diabetic diseases. Genetic disease data
were imported from OMIM Morbid Map and the terminologies
were normalised to UMLS, which was used as the disease termi-
nology source.
Prototype Virtual Knowledge Broker services
The prototype SESL demonstrator shows how an open semantic
web infrastructure can integrate different primary data sources as
VKB services. This approach makes it straightforward to ensure
that any duplicated data from two distinct primary data resources
displays unique information in the graphical user interface of the
demonstrator. The VKB layer resolves duplicate data from the
multiple primary data sources. It extracts assertions and metadata
from the primary sources and transforms the extracted data into
RDF triples. Following semantic normalisation, the processed data
are accessible from a RDF triple store through a SPARQL endpoint
[http://www.w3.org/TR/rdf-sparql-query]. The architecture is
described in Fig. 2.
The integration of content from different information providers
is particularly beneficial as they often render different interpreta-
tions from the same data resources (Fig. 3). For example, the threeFull text
literature 
‘Supplier’
firewall
UniProt
‘Consumer’
firewall
Multiple con
Assertion and meta data ex
Transform to RDF triples
Integrator/aggregator (triple
Gene-disease qu
Open
standards
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FIGURE 2
Architecture of the Virtual Knowledge Broker (VKB) service. The VKB service layer c
rules to determine data extraction, transformation of extracted data to RDF triples,
SPARQL endpoint. Abbreviations: OMIM: Online Mendelian Inheritance in Man; RDgenes LIPC, SLC30A8 and UCP1 are linked to diabetes according to
UniProt, but the disease stems from the ‘polymorphisms’ field
rather than the field named ‘Involvement in disease’. By applying
existing open data standards in a consistent manner, it is possible
to export all the relevant data into a single infrastructure.
The SESL demonstrator brokers static data resources in RDF that
stem from selected public bioinformatics databases and the pub-
lication corpus, as described above. A set of triple stores comprising
the broker system have been tested for their flexibility and exten-
sibility. It has proven possible to distribute the brokered data
services over different compute engines in a federated grid cluster.
This approach offers flexibility so that static RDF resources can be
redistributed freely, loaded into any decentralised location and
also be kept in traditional relational databases.
The SESL graphical user interface, illustrated in Fig. 4, shows
how a single query, for example, for a gene name, returns an
aggregated set of gene and disease relationships, where the results
are derived from multiple primary data sources [22]. Therefore, the
SESL demonstrator shows that it is technically feasible to deliver
semantic integration of primary data sources through VKB ser-
vices. This approach has the potential to simplify and improve the
user experience and to more fully explore all the information
available about entities such as genes associated with a disease,
including any conflicting assertions.
The role of semantic web standards
Semantic web technologies and standards are particularly well
suited to accomplish data aggregation and integration [23,24],
but require full implementation of open semantic web standards
to realise the potential to reduce data redundancy and improve
consistency across the disparate sources.
Standardising the assertions from the scientific literature requires
the reuse of public semantic resources such as UMLS [20] and
BioLexicon/LexEBI [25]. It is also important to use existing metadataOMIM Array
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omprises assertion and metadata extraction from primary sources, business
 public vocabularies, the triple store for integration and aggregation and the
F: Resource Description Framework.
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FIGURE 3
Minimal configuration to test technical feasibility. The minimal configuration to test for de-duplication of data in a virtual knowledge brokering service is shown
conceptually, where two triple stores have identical structure, but primary source content can overlap. UniProtKB content was used to test this condition.
Abbreviations: OMIM: Online Mendelian Inheritance in Man; NPG: Nature Publishing Group; OUP: Oxford University Press; RSC: Royal Society of Chemistry.
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reference] and Dublin Core [http://dublincore.org/documents/
2010/10/11/dcmi-terms]. This enables interoperability and seam-
less integration of all literature content with other data resources
while lowering the overhead costs for any literature providers to
participate. Other relevant standards that should be considered
include MIBBI [27] and the Open Archive Initiative Protocol for
Metadata Harvesting [http://www.openarchives.org/pmh]. For the
SESL demonstrator, the extracted assertions have been represented
as RDF triples and used as a minimum information entity from the
scientific literature. Such assertions can be formally combined with
provenance to give ‘nanopublications’ which enable microattribu-
tion [28]. Nanopublications rather than narrative full text articles
have also been proposed as an alternative central information unit
for future scholarly communication [29].
Standards are already available to achieve semantic interoper-
ability of distributed and redundant data repositories using seman-
tic web technology, and scientific literature providers can make
use of these existing standards to be compliant. However, access to
and processing of the literature through a text mining service is
still necessary to deliver the assertions that support the brokering
approach. An increasing number of publishers and data providers
are already getting involved in activities, either in-house or work-
ing together in precompetitive consortia, to move towards data
and literature content being colocated or associated in such a432 www.drugdiscoverytoday.commanner that they can be exploited using the semantic web
[21,31–33].
It is conceivable that analytical software tools on the web could
identify suitably tagged data stored in suitable primary reposi-
tories with minimal external influence. Such semantically tagged
data resources could self-register for sharing or licensing condi-
tions before consumption by analytical web services that produce
and consume RDF as automated workflows. Examples of such
open semantic frameworks are the SSWAP (Simple Semantic Web
Architecture and Protocol), SADI/SHARE and S3DB semantic web
frameworks [14,30]. SHARE exposes SADI web services as if they
were a virtual, distributed SPARQL endpoint to achieve semantic
integration.
Sharing precompetitive competencies
The SESL pilot project set out to evaluate the feasibility of using
open semantic web standards to build a knowledge brokering
system for life science data. It was commissioned by the Pistoia
Alliance, which is a precompetitive alliance of life science orga-
nisations and institutions. The SESL project team comprises repre-
sentatives from five large companies engaged in life science
research (Pfizer, GlaxoSmithKline, AstraZeneca, Unilever and
Hoffmann-LaRoche), three scholarly publishers (Oxford Univer-
sity Press, Nature Publishing Group and Elsevier), one learned
society (Royal Society of Chemistry) and an academic partner
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•  Please note that this proof of principle demonstrator gives
 access  to information that has been extracted selectively
 from different bioinformatics resources.
•  This demonstrator also includes a limited sample of the 
 scientific literature from four publishers and is focussed on 
 diseases related to Type 2 Diabetes mellitus.
SESL Public Demonstrator:
FIGURE 4
The SESL public demonstrator for Virtual Knowledge Broker (VKB) services. The simple graphical user interface (GUI) is shown schematically to illustrate an
exemplar VKB service where a single query by gene and/or disease can return a single set of aggregated results for gene and disease relationships derived from
numerous primary data sources. Abbreviations: OMIM: Online Mendelian Inheritance in Man; SESL: Semantic Enrichment of the Scientific Literature.
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W(EMBL-EBI). Each representative brought different expertise and
views to the team, with all recognising a common set of chal-
lenges, these include:
(i) the large volume and complexity of life science data and
published literature is now beyond the ability of a single user
or organisation to query or manage in a comprehensive and
cost effective manner;
(ii) open semantic web standards need to be supported and
promoted to encourage their widespread adoption;
(iii) data providers are the experts in the technologies required
for management and integration of their data;
(iv) users need to be able to readily access and exploit all available
data in a timely manner;
(v) value can be added to data by effective aggregation of many
primary data sources.
By working together in a precompetitive manner we have
shown that existing open semantic web standards and technolo-
gies are sufficient to integrate data from numerous primary data
sources. This will bring benefit to both data consumers and pro-
viders working in life sciences.
Concluding remarks
In this perspective we have discussed the challenges and oppor-
tunities raised by the growing deluge of data being generated in
life sciences. We have placed particular emphasis on semantics-
driven approaches to improve data integration and access
through VKB services. The SESL project has developed a public
demonstrator that, for the first time, shows that existing opensemantic web standards and technologies are sufficient to
integrate structured and unstructured data derived from a
selection of public and proprietary data sources. This fully
functional prototype has been developed over a period of
approximately one year and on a modest budget. It shows
how a precompetitive consortium, comprising of members from
different parts of the scientific community can share costs and
risks to demonstrate technical feasibility for data integration
through VKB services.
Looking to the future, principles similar to those used in the
SESL project are being applied by the Open PHACTS (Open PhAr-
macological Concepts Triple Store) consortium, which is funded
by the Innovative Medicines Initiative (IMI) for three years. Open-
PHACTS brings together academic and pharmaceutical partners to
design and implement an open source, open standards and open
access innovation platform, the Open Pharmacological Space
(OPS) that is designed to deliver semantic interoperability for drug
discovery [33].
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